▶ 調査レポート

世界のラノラジン市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Ranolazine Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のラノラジン市場規模・現状・予測(2021年-2027年) / Global Ranolazine Market Size, Status and Forecast 2021-2027 / QFJ1-5981資料のイメージです。• レポートコード:QFJ1-5981
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、88ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、ラノラジンの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(500mg錠、1000mg錠)、用途別市場規模(病院、ドラッグストア)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・ラノラジンの市場動向
・企業の競争状況、市場シェア
・ラノラジンの種類別市場規模と予測2016-2027(500mg錠、1000mg錠)
・ラノラジンの用途別市場規模と予測2016-2027(病院、ドラッグストア)
・ラノラジンの北米市場規模2016-2027(アメリカ、カナダ)
・ラノラジンの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・ラノラジンのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・ラノラジンの中南米市場規模2016-2027(メキシコ、ブラジル)
・ラノラジンの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Gilead Sciences、Lupin、Teva、Ajanta Pharma)
・結論

Ranolazine, sold under the trade name Ranexa by Gilead Sciences, is a drug to treat angina that was first approved in 2006.

Market Analysis and Insights: Global Ranolazine Market
The global Ranolazine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ranolazine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ranolazine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ranolazine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ranolazine market.

Global Ranolazine Scope and Market Size
Ranolazine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ranolazine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
500 mg Tablet
1000 mg Tablet

Segment by Application
Hospital
Drug store

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Gilead Sciences
Lupin
Teva
Ajanta Pharma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ranolazine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 500 mg Tablet
1.2.3 1000 mg Tablet
1.3 Market by Application
1.3.1 Global Ranolazine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ranolazine Market Perspective (2016-2027)
2.2 Ranolazine Growth Trends by Regions
2.2.1 Ranolazine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ranolazine Historic Market Share by Regions (2016-2021)
2.2.3 Ranolazine Forecasted Market Size by Regions (2022-2027)
2.3 Ranolazine Industry Dynamic
2.3.1 Ranolazine Market Trends
2.3.2 Ranolazine Market Drivers
2.3.3 Ranolazine Market Challenges
2.3.4 Ranolazine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ranolazine Players by Revenue
3.1.1 Global Top Ranolazine Players by Revenue (2016-2021)
3.1.2 Global Ranolazine Revenue Market Share by Players (2016-2021)
3.2 Global Ranolazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ranolazine Revenue
3.4 Global Ranolazine Market Concentration Ratio
3.4.1 Global Ranolazine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ranolazine Revenue in 2020
3.5 Ranolazine Key Players Head office and Area Served
3.6 Key Players Ranolazine Product Solution and Service
3.7 Date of Enter into Ranolazine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ranolazine Breakdown Data by Type
4.1 Global Ranolazine Historic Market Size by Type (2016-2021)
4.2 Global Ranolazine Forecasted Market Size by Type (2022-2027)

5 Ranolazine Breakdown Data by Application
5.1 Global Ranolazine Historic Market Size by Application (2016-2021)
5.2 Global Ranolazine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ranolazine Market Size (2016-2027)
6.2 North America Ranolazine Market Size by Type
6.2.1 North America Ranolazine Market Size by Type (2016-2021)
6.2.2 North America Ranolazine Market Size by Type (2022-2027)
6.2.3 North America Ranolazine Market Size by Type (2016-2027)
6.3 North America Ranolazine Market Size by Application
6.3.1 North America Ranolazine Market Size by Application (2016-2021)
6.3.2 North America Ranolazine Market Size by Application (2022-2027)
6.3.3 North America Ranolazine Market Size by Application (2016-2027)
6.4 North America Ranolazine Market Size by Country
6.4.1 North America Ranolazine Market Size by Country (2016-2021)
6.4.2 North America Ranolazine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Ranolazine Market Size (2016-2027)
7.2 Europe Ranolazine Market Size by Type
7.2.1 Europe Ranolazine Market Size by Type (2016-2021)
7.2.2 Europe Ranolazine Market Size by Type (2022-2027)
7.2.3 Europe Ranolazine Market Size by Type (2016-2027)
7.3 Europe Ranolazine Market Size by Application
7.3.1 Europe Ranolazine Market Size by Application (2016-2021)
7.3.2 Europe Ranolazine Market Size by Application (2022-2027)
7.3.3 Europe Ranolazine Market Size by Application (2016-2027)
7.4 Europe Ranolazine Market Size by Country
7.4.1 Europe Ranolazine Market Size by Country (2016-2021)
7.4.2 Europe Ranolazine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ranolazine Market Size (2016-2027)
8.2 Asia-Pacific Ranolazine Market Size by Type
8.2.1 Asia-Pacific Ranolazine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ranolazine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ranolazine Market Size by Type (2016-2027)
8.3 Asia-Pacific Ranolazine Market Size by Application
8.3.1 Asia-Pacific Ranolazine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ranolazine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ranolazine Market Size by Application (2016-2027)
8.4 Asia-Pacific Ranolazine Market Size by Region
8.4.1 Asia-Pacific Ranolazine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ranolazine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ranolazine Market Size (2016-2027)
9.2 Latin America Ranolazine Market Size by Type
9.2.1 Latin America Ranolazine Market Size by Type (2016-2021)
9.2.2 Latin America Ranolazine Market Size by Type (2022-2027)
9.2.3 Latin America Ranolazine Market Size by Type (2016-2027)
9.3 Latin America Ranolazine Market Size by Application
9.3.1 Latin America Ranolazine Market Size by Application (2016-2021)
9.3.2 Latin America Ranolazine Market Size by Application (2022-2027)
9.3.3 Latin America Ranolazine Market Size by Application (2016-2027)
9.4 Latin America Ranolazine Market Size by Country
9.4.1 Latin America Ranolazine Market Size by Country (2016-2021)
9.4.2 Latin America Ranolazine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ranolazine Market Size (2016-2027)
10.2 Middle East & Africa Ranolazine Market Size by Type
10.2.1 Middle East & Africa Ranolazine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ranolazine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ranolazine Market Size by Type (2016-2027)
10.3 Middle East & Africa Ranolazine Market Size by Application
10.3.1 Middle East & Africa Ranolazine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ranolazine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ranolazine Market Size by Application (2016-2027)
10.4 Middle East & Africa Ranolazine Market Size by Country
10.4.1 Middle East & Africa Ranolazine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ranolazine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Ranolazine Introduction
11.1.4 Gilead Sciences Revenue in Ranolazine Business (2016-2021)
11.1.5 Gilead Sciences Recent Development
11.2 Lupin
11.2.1 Lupin Company Details
11.2.2 Lupin Business Overview
11.2.3 Lupin Ranolazine Introduction
11.2.4 Lupin Revenue in Ranolazine Business (2016-2021)
11.2.5 Lupin Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Ranolazine Introduction
11.3.4 Teva Revenue in Ranolazine Business (2016-2021)
11.3.5 Teva Recent Development
11.4 Ajanta Pharma
11.4.1 Ajanta Pharma Company Details
11.4.2 Ajanta Pharma Business Overview
11.4.3 Ajanta Pharma Ranolazine Introduction
11.4.4 Ajanta Pharma Revenue in Ranolazine Business (2016-2021)
11.4.5 Ajanta Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ranolazine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 500 mg Tablet
Table 3. Key Players of 1000 mg Tablet
Table 4. Global Ranolazine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Ranolazine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Ranolazine Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Ranolazine Market Share by Regions (2016-2021)
Table 8. Global Ranolazine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Ranolazine Market Share by Regions (2022-2027)
Table 10. Ranolazine Market Trends
Table 11. Ranolazine Market Drivers
Table 12. Ranolazine Market Challenges
Table 13. Ranolazine Market Restraints
Table 14. Global Ranolazine Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Ranolazine Market Share by Players (2016-2021)
Table 16. Global Top Ranolazine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ranolazine as of 2020)
Table 17. Ranking of Global Top Ranolazine Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Ranolazine Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Ranolazine Product Solution and Service
Table 21. Date of Enter into Ranolazine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ranolazine Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Ranolazine Revenue Market Share by Type (2016-2021)
Table 25. Global Ranolazine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Ranolazine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Ranolazine Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Ranolazine Revenue Market Share by Application (2016-2021)
Table 29. Global Ranolazine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Ranolazine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Ranolazine Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Ranolazine Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Ranolazine Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Ranolazine Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Ranolazine Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Ranolazine Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Ranolazine Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Ranolazine Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Ranolazine Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Ranolazine Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Ranolazine Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Ranolazine Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Ranolazine Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Ranolazine Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Ranolazine Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Ranolazine Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ranolazine Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Ranolazine Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Ranolazine Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Ranolazine Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Ranolazine Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Ranolazine Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Ranolazine Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Ranolazine Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Ranolazine Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Ranolazine Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Ranolazine Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Ranolazine Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ranolazine Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Ranolazine Market Size by Country (2022-2027) & (US$ Million)
Table 61. Gilead Sciences Company Details
Table 62. Gilead Sciences Business Overview
Table 63. Gilead Sciences Ranolazine Product
Table 64. Gilead Sciences Revenue in Ranolazine Business (2016-2021) & (US$ Million)
Table 65. Gilead Sciences Recent Development
Table 66. Lupin Company Details
Table 67. Lupin Business Overview
Table 68. Lupin Ranolazine Product
Table 69. Lupin Revenue in Ranolazine Business (2016-2021) & (US$ Million)
Table 70. Lupin Recent Development
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Ranolazine Product
Table 74. Teva Revenue in Ranolazine Business (2016-2021) & (US$ Million)
Table 75. Teva Recent Development
Table 76. Ajanta Pharma Company Details
Table 77. Ajanta Pharma Business Overview
Table 78. Ajanta Pharma Ranolazine Product
Table 79. Ajanta Pharma Revenue in Ranolazine Business (2016-2021) & (US$ Million)
Table 80. Ajanta Pharma Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ranolazine Market Share by Type: 2020 VS 2027
Figure 2. 500 mg Tablet Features
Figure 3. 1000 mg Tablet Features
Figure 4. Global Ranolazine Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drug store Case Studies
Figure 7. Ranolazine Report Years Considered
Figure 8. Global Ranolazine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Ranolazine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Ranolazine Market Share by Regions: 2020 VS 2027
Figure 11. Global Ranolazine Market Share by Regions (2022-2027)
Figure 12. Global Ranolazine Market Share by Players in 2020
Figure 13. Global Top Ranolazine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ranolazine as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Ranolazine Revenue in 2020
Figure 15. Global Ranolazine Revenue Market Share by Type (2016-2021)
Figure 16. Global Ranolazine Revenue Market Share by Type (2022-2027)
Figure 17. North America Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Ranolazine Market Share by Type (2016-2027)
Figure 19. North America Ranolazine Market Share by Application (2016-2027)
Figure 20. North America Ranolazine Market Share by Country (2016-2027)
Figure 21. United States Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Ranolazine Market Share by Type (2016-2027)
Figure 25. Europe Ranolazine Market Share by Application (2016-2027)
Figure 26. Europe Ranolazine Market Share by Country (2016-2027)
Figure 27. Germany Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Ranolazine Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Ranolazine Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Ranolazine Market Share by Region (2016-2027)
Figure 37. China Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Ranolazine Market Share by Type (2016-2027)
Figure 45. Latin America Ranolazine Market Share by Application (2016-2027)
Figure 46. Latin America Ranolazine Market Share by Country (2016-2027)
Figure 47. Mexico Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Ranolazine Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Ranolazine Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Ranolazine Market Share by Country (2016-2027)
Figure 53. Turkey Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Ranolazine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Gilead Sciences Revenue Growth Rate in Ranolazine Business (2016-2021)
Figure 57. Lupin Revenue Growth Rate in Ranolazine Business (2016-2021)
Figure 58. Teva Revenue Growth Rate in Ranolazine Business (2016-2021)
Figure 59. Ajanta Pharma Revenue Growth Rate in Ranolazine Business (2016-2021)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed